tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Gilead Sciences Inc

GILD
Add to Watchlist
150.110USD
-0.780-0.52%
Close 09-18 16:00（ET）
186.17BMarket Cap
20.24P/E TTM
Pre-market 04:00 (ET)149.890USD-0.220-0.15%

Gilead Sciences Inc

150.110
-0.780-0.52%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

GILD Financials

See Gilead Sciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
186.17B
Dividend TTM
3.19
P/E TTM
20.24
EPS TTM
7.41
Revenue
29.44B
Net Profit
480.00M
ROE
43.19%
ROA
16.35%

Gilead Sciences Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
-8.44/-7.24
Revenue / Forecast
7.80B/7.40B

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-636.37%-8.44
54.18%1.63
378.44%6.84
144.36%2.46
21.63%1.57
131.56%1.06
24.57%1.43
-42.48%1.00
54.70%1.29
-513.21%-3.34
-12.17%1.15
--1.75
--0.84
--0.81
--1.31
----
----
----
----
----
Revenue
10.18%7.80B
4.39%6.96B
4.70%7.92B
2.97%7.77B
1.84%7.08B
-0.28%6.67B
6.40%7.57B
7.01%7.54B
5.38%6.95B
5.26%6.69B
-3.72%7.11B
0.13%7.05B
5.42%6.60B
-3.61%6.35B
2.00%7.39B
-5.11%7.04B
0.69%6.26B
2.60%6.59B
-2.39%7.24B
12.83%7.42B
Net Profit
-635.51%-10.50B
53.69%2.02B
22.43%2.18B
143.58%3.05B
21.44%1.96B
131.53%1.31B
24.77%1.78B
-42.52%1.25B
54.45%1.61B
-512.87%-4.17B
-12.87%1.43B
21.86%2.18B
-8.65%1.04B
5215.79%1.01B
329.32%1.64B
-30.98%1.79B
-24.84%1.14B
-98.90%19.00M
-75.37%382.00M
620.00%2.59B
Net Margin
-586.03%-134.51%
47.22%29.04%
22.70%28.90%
136.55%39.28%
19.24%27.68%
131.62%19.72%
18.27%23.56%
-46.09%16.61%
47.41%23.21%
-502.20%-62.37%
-9.87%19.92%
--30.80%
--15.74%
--15.51%
--22.10%
----
----
----
----
----
Gross Margin
1.22%79.76%
3.04%79.24%
-0.36%78.83%
0.84%79.80%
1.30%78.81%
0.15%76.90%
2.27%79.11%
1.71%79.14%
-0.45%77.80%
-1.48%76.79%
-4.63%77.35%
--77.80%
--78.15%
--77.94%
--81.11%
----
----
----
----
----
Debt to assets ratio
18.76%53.17%
-10.89%39.40%
-6.69%42.25%
--42.61%
2.73%44.77%
-1.21%44.21%
12.57%45.28%
----
7.61%43.58%
9.72%44.76%
0.70%40.22%
--40.05%
--40.50%
--40.79%
--39.94%
----
----
----
----
----
Income Statement
Revenue
10.18%7.80B
4.39%6.96B
4.70%7.92B
2.97%7.77B
1.84%7.08B
-0.28%6.67B
6.40%7.57B
7.01%7.54B
5.38%6.95B
5.26%6.69B
-3.72%7.11B
0.13%7.05B
5.42%6.60B
-3.61%6.35B
2.00%7.39B
-5.11%7.04B
0.69%6.26B
2.60%6.59B
-2.39%7.24B
12.83%7.42B
Operating profit
-6.65%2.56B
6.55%2.73B
17.12%2.96B
10.69%3.51B
1.29%2.74B
5.25%2.56B
-0.47%2.52B
16.84%3.17B
11.42%2.70B
11.44%2.44B
-10.42%2.54B
-17.38%2.71B
2.84%2.43B
-24.54%2.19B
201.17%2.83B
-14.92%3.29B
0.73%2.36B
-2.23%2.90B
-65.38%940.00M
21.72%3.86B
Net Profit
-635.51%-10.50B
53.69%2.02B
22.43%2.18B
143.58%3.05B
21.44%1.96B
131.53%1.31B
24.77%1.78B
-42.52%1.25B
54.45%1.61B
-512.87%-4.17B
-12.87%1.43B
21.86%2.18B
-8.65%1.04B
5215.79%1.01B
329.32%1.64B
-30.98%1.79B
-24.84%1.14B
-98.90%19.00M
-75.37%382.00M
620.00%2.59B
Balance Sheet
Current assets
-5.25%13.95B
15.84%18.64B
-4.33%18.34B
20.94%17.87B
19.49%14.72B
14.61%16.09B
19.20%19.17B
-7.52%14.78B
-13.79%12.32B
4.35%14.04B
11.37%16.09B
17.90%15.98B
8.44%14.29B
6.55%13.46B
-2.23%14.44B
-3.12%13.55B
-5.39%13.18B
-4.89%12.63B
-7.65%14.77B
-54.76%13.99B
Total current liabilities
-1.51%11.02B
-23.23%9.48B
-1.59%11.81B
4.89%12.30B
3.78%11.19B
-5.16%12.34B
6.42%12.00B
-1.84%11.72B
-22.79%10.78B
23.62%13.02B
0.38%11.28B
14.60%11.95B
51.45%13.96B
23.02%10.53B
-3.21%11.24B
1.74%10.42B
-9.73%9.22B
-11.82%8.56B
1.87%11.61B
7.74%10.24B
Total assets
-11.41%49.36B
-0.28%56.28B
0.05%59.02B
7.35%58.53B
4.00%55.72B
0.25%56.43B
-5.04%58.99B
-12.58%54.52B
-14.05%53.58B
-9.02%56.29B
-1.66%62.13B
-0.29%62.37B
-0.85%62.34B
-1.91%61.88B
-7.04%63.17B
-6.77%62.56B
-7.52%62.87B
-6.54%63.08B
-0.67%67.95B
10.22%67.10B
Total liabilities
4.12%37.62B
-12.07%32.85B
-8.41%36.41B
2.61%37.08B
2.12%36.13B
-3.81%37.36B
0.95%39.75B
-9.96%36.13B
-14.21%35.38B
-5.13%38.84B
-6.16%39.38B
-3.30%40.13B
-3.31%41.24B
-5.16%40.94B
-10.51%41.96B
-9.05%41.50B
-11.64%42.66B
-11.05%43.16B
-6.57%46.89B
5.11%45.63B
Total equity
-40.05%11.74B
22.82%23.43B
17.52%22.62B
16.67%21.46B
7.66%19.59B
9.30%19.08B
-15.40%19.25B
-17.32%18.39B
-13.73%18.20B
-16.64%17.45B
7.26%22.75B
5.63%22.24B
4.35%21.09B
5.14%20.94B
0.69%21.21B
-1.93%21.06B
2.56%20.21B
5.01%19.91B
15.60%21.06B
22.90%21.47B
Cash Flow Statement
Net operating income
331.92%3.57B
44.79%2.54B
11.80%3.33B
-4.66%4.11B
-37.58%827.00M
-20.82%1.76B
37.16%2.98B
145.53%4.31B
-43.35%1.32B
27.31%2.22B
-15.50%2.17B
-38.70%1.75B
29.80%2.34B
-5.27%1.74B
-19.91%2.57B
-11.99%2.86B
-22.19%1.80B
-29.50%1.84B
67.28%3.21B
44.58%3.25B
Net investment
-388.99%-10.35B
526.27%1.77B
-715.56%-1.83B
39.86%-427.00M
-589.25%-2.12B
81.20%-415.00M
69.05%-225.00M
-210.04%-710.00M
36.44%-307.00M
-167.19%-2.21B
-93.87%-727.00M
67.88%-229.00M
-56.82%-483.00M
22.80%-826.00M
-34.89%-375.00M
-204.70%-713.00M
46.62%-308.00M
47.60%-1.07B
96.90%-278.00M
13.65%-234.00M
Net financing
249.59%2.34B
-23.70%-4.24B
-155.88%-1.26B
-7.98%-1.49B
46.94%-1.57B
-151.73%-3.43B
305.64%2.26B
9.22%-1.38B
-168.21%-2.95B
3.20%-1.36B
29.28%-1.10B
28.28%-1.52B
-9.77%-1.10B
21.63%-1.41B
19.98%-1.55B
39.95%-2.12B
-7.73%-1.00B
27.57%-1.79B
-1582.44%-1.94B
-185.52%-3.53B

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its total revenue reached 29.44B, with a year-on-year change of 28.75B.

What are the current assets of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its current assets were 18.34B, with a year-on-year change of -4.33.

What are the total assets of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its total assets of Gilead Sciences Inc were 59.02B, with a year-on-year change of 0.05.

What are the total liabilities of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its total liabilities of Gilead Sciences Inc were 36.41B, with a year-on-year change of -8.41.

What is the total equity of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its total equity of Gilead Sciences Inc was 22.62B, with a year-on-year change of 17.52.

What is the net operating income of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its net operating income of Gilead Sciences Inc was 11.77B, with a year-on-year change of 8.74.

What is the net investment of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its net investment of Gilead Sciences Inc was -4.79B, with a year-on-year change of -38.97.

What is the net financing of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its net financing of Gilead Sciences Inc was -7.75B, with a year-on-year change of -125.60.

What is the Earnings Per Share (EPS) of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 6.84, with a year-on-year change of 1677.21.

What is the net income of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its net income was 8.51B, with a year-on-year change of 1672.92.

What is the net margin of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its net profit margin was 28.90, with a year-on-year change of 1631.43.

What is the gross margin of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its gross margin was 78.84, with a year-on-year change of 0.74.

What is the debt-to-asset ratio of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its debt-to-asset ratio was 42.25, with a year-on-year change of -6.69.

What is the Return on Equity (ROE) of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its Return on Equity (ROE) was 40.49, with a year-on-year change of 1678.44.

What is the Return on Assets (ROA) of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its Return on Assets (ROA) was 14.42, with a year-on-year change of 1719.52.

What is the operating profit of Gilead Sciences Inc?

According to Gilead Sciences Inc's FY2025 earnings report, its operating profit was 11.77B, with a year-on-year change of 8.74.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy